In a landmark move, the U.S. Department of Justice initiated a formal rulemaking process in May 2024 to reschedule marijuana from a Schedule I to a Schedule III substance under the Controlled Substances Act. This proposal, influenced by recommendations from the Department of Health and Human Services, acknowledges marijuana's accepted medical use and aims to reduce federal … [Read more...] about Federal Developments: Rescheduling and Legislative Initiatives
DEA
Federal Cannabis Reform: Rescheduling Efforts Face Political Hurdles and Industry Uncertainty
In 2024, the U.S. cannabis industry witnessed significant developments, including the Drug Enforcement Administration's (DEA) decision to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act. This move marked a major step towards federal legalization, allowing state-licensed cannabis businesses to take federal tax deductions and removing … [Read more...] about Federal Cannabis Reform: Rescheduling Efforts Face Political Hurdles and Industry Uncertainty
DEA Struggles to Fill Ranks Amid Budget Cuts and Shifting Public Opinion
The Drug Enforcement Administration (DEA) is having a hard time recruiting new agents, and it’s not just about the money—though that’s part of it.Faced with budget constraints and increasing criticism of the drug war, the DEA’s recruitment campaigns are falling flat. Despite attempts to modernize outreach—including the use of memes and quirky internet culture—the agency has … [Read more...] about DEA Struggles to Fill Ranks Amid Budget Cuts and Shifting Public Opinion
I Called the White House About Weed and Now I’m Pretty Sure I’m on a List
Let me tell you something about anxiety: it doesn’t knock. It kicks in the door, spills bong water on your foot, and asks if you have a minute to talk about consequences.It started with a dare I made to myself during a particularly vicious weed nap. “Call the White House,” I thought. “Just ring 'em up. Ask what the hell is going on with marijuana reform.” Easy, right? I mean, … [Read more...] about I Called the White House About Weed and Now I’m Pretty Sure I’m on a List
Trump’s New DEA Leader Has A ‘Just Say No’ Stance On Marijuana, Linking Cannabis Use To Suicide Risk And Schizophrenia
President Donald Trump has officially named his pick to lead the Drug Enforcement Administration (DEA)—selecting a decades-long agency veteran and top Virginia official who’s voiced concerns about the dangers of marijuana and linked its use to higher suicide risk among youth. On Tuesday, Trump announced that he’s nominating Terrance Cole to serve as DEA administrator in place … [Read more...] about Trump’s New DEA Leader Has A ‘Just Say No’ Stance On Marijuana, Linking Cannabis Use To Suicide Risk And Schizophrenia
Trump’s DEA Pick
The Trump administration appointed Derek S. Maltz as the acting administrator of the U.S. Drug Enforcement Administration (DEA). A 28-year veteran of the agency, Maltz is known for his hardline stance on cannabis and drug policy. Maltz has criticized cannabis legalization, citing its alleged links to public safety concerns, and accused the Department of Justice of politicizing … [Read more...] about Trump’s DEA Pick
DEA Responds to ‘Out of Time’ Cannabis Rescheduling Claims
That’s a quick summary of the Drug Enforcement Administration’s (DEA) 12-page response to cannabis rescheduling advocates, who filed a Jan. 6 motion for DEA Chief Administrative Law Judge (ALJ) John J. Mulrooney to reconsider the DEA’s role as the proponent of a proposed rule to reclassify cannabis in the upcoming hearing process. The hearing is scheduled to resume with expert … [Read more...] about DEA Responds to ‘Out of Time’ Cannabis Rescheduling Claims
New Evidence Shows DEA Opposes Marijuana Rescheduling And Should Be Removed From Hearings, Cannabis Groups Say
Attorneys for a cannabis company and advocacy group that are set to testify in the Drug Enforcement Administration’s (DEA) marijuana rescheduling hearing process beginning this month say new evidence has come to light revealing that the agency actually opposes the proposed rule it is supposed to defend and has engaged in improper communications with other opponents of the … [Read more...] about New Evidence Shows DEA Opposes Marijuana Rescheduling And Should Be Removed From Hearings, Cannabis Groups Say
Judge Calls DEA Subpoena Request ‘Blunder,’ Rejects 3 of 4 for Cannabis Rescheduling Hearing
The Drug Enforcement Administration (DEA) made a major blunder in its subpoena request for witnesses in the upcoming cannabis rescheduling hearing. Still, an administrative law judge (ALJ) appears to be giving the agency another shot. DEA Chief ALJ John J. Mulrooney issued an order dated Dec. 16 granting the DEA just one of its four subpoena requests made Dec. 13 for Food and … [Read more...] about Judge Calls DEA Subpoena Request ‘Blunder,’ Rejects 3 of 4 for Cannabis Rescheduling Hearing
Cannabis Research Company Asks DEA Judge To Let Young Medical Marijuana Patient Testify At Rescheduling Hearing
A cannabis research company is asking a Drug Enforcement Administration (DEA) judge to allow it to add a young medical marijuana patient and advocate as a witness in an upcoming hearing on the Biden administration’s proposal to reschedule the drug. In a letter brief sent to DEA Administrative Law Judge (ALJ) John Mulrooney on Friday, Cannabis Bioscience International Holdings … [Read more...] about Cannabis Research Company Asks DEA Judge To Let Young Medical Marijuana Patient Testify At Rescheduling Hearing
